United Therapeutics buy UBS Group AG
Start price
08.01.25
/
50%
€355.30
Target price
08.01.26
€460.94
Performance (%)
-29.58%
Price
02.07.25
€250.20
Summary
This prediction is currently active. The price of United Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -29.58%. This prediction currently runs until 08.01.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 1.998% | 1.998% |
| iShares Core DAX® | 1.263% | -1.123% |
| iShares Nasdaq 100 | 0.531% | 2.176% |
| iShares Nikkei 225® | 1.532% | 1.686% |
| iShares S&P 500 | 0.904% | 1.784% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $415.00 to $475.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
2.50%
02.07.25
02.07.25
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.55%
02.07.25
02.07.25